Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the ...

In this video interview, Umesh Chaudhari, executive medical director and global program head of the C5 programs at Regeneron, ...

Expert.ai, a leading provider of enterprise artificial intelligence solutions for business value creation, and Springer ...

A majority of cancer drugs approved in the US during 2019-2022 had “clinical trial uncertainties,” research suggests.

Site networks can be a powerful engine for this kind of change. When built on collaboration, not control, and focused on capability over conformity, they allow more sites to engage in research, more ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

The CORE-MD (Coordinating Research and Evidence for high-risk Medical Devices) consortium has published new consensus ...

These findings offer real hope for a population that has long needed better solutions." Study Design & Patient Experience The RELIEV-CM Pilot Study was a prospective, multi-center clinical ...

Asan Medical Center is a reference hospital and the teaching hospital of the University of Ulsan College of Medicine, located in Seoul, South Korea. With 2,432 beds for patients and a total floor area ...

This article concludes our three-part series on preparing cell and gene therapies (CGTs) for successful launch and long-term ...

Feeding infants blueberries as one of their first solid foods could help strengthen their immune systems and support ...